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T cells genetically modified to express a CD19-specific
chimeric antigen receptor (CAR) for the investigational
treatment of B cell malignancies comprise a heterogeneous
population, and their ability to persist and participate in
serial killing of tumor cells is a predictor of therapeutic
success. We developed Timelapse Imaging Microscopy In
Nanowell Grids (TIMING) to dynamically analyze thou-
sands of interactions between T cells and tumor cells. Our
results demonstrate that while CAR+ T cells launch fully-
competent anti-tumor responses as defined by polarized
motility, serial-killing and IFN-g secretion, the cytolytic
functionality of CAR+ T cells must be quantified in the
context of their ability to resist apoptosis. The ability of
killer CAR+ T cells to adaptively modify both cell-intrinsic
(polarization and motility) and extrinsic (conjugation and
kinetics of tumor-cell death) behavior was modulated by
number of tumor cell encounters. By comparing both the
serial killer and single killer CAR+ T cells it appears that
the propensity and kinetics of effector apoptosis was
markedly different, effectors underwent apoptosis at
higher frequencies (50%, single target killers, vs 28%, serial
killers) and faster kinetics (time to apoptosis: 256 ± 12
minutes, single target; vs. 396 ± 25 minutes, multiple
targets; p-value < 0.0001) (Figure 1). These data indicate
that activation for lysis through multiple targets as
opposed to prolonged contact with a single target reduces
the propensity for effector apoptosis. Although the
mechanistic basis for the responsiveness of these T cells to
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Figure 1 Frequency and kinetics of effector apoptosis are dependent on functional activation by varying numbers of tumor cells. (A)
Box and whisker plots (extremities indicate range) of the distribution of single CAR+ T cells undergoing AICD. (B) Donor variation in the average
frequencies of apoptotic killer CAR+ T cells. P-values were computed using an unpaired two-tailed t-test.
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antigen/target density is not known, it is conceivable that
the continuous propagation of these cells on irradiated
aAPC at defined ratios, allows for balanced activation
while minimizing AICD. These data could provide
mechanistic insights into observations that infused CAR+
T cells swell in number and produce high levels of
cytokine in response to addressing large numbers of
CD19+ tumor cells, but then decline in number as the
tumor bioburden is lowered due to the serial killing by
effector T cells. Our findings emphasize the notion that
motility and persistence (resistance to apoptosis), in addi-
tion to direct cytolytic activity, may serve as criteria to
rapidly evaluate CAR+ T cell potency. We anticipate that
our findings and the TIMING methodology may provide a
rapid approach for assessing the impact of CAR designs
and sub-populations of cells modified to redirect
specificity.
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